Evidence map›Paper›PMID 38503924›Full record

ArticleMolecular psychiatry2024

Data-driven, connectome-wide analysis identifies psychosis-specific brain correlates of fear and anxiety.

Brandee Feola, Adam Beermann, Karlos Manzanarez Felix, Michael Coleman, Sylvain Bouix, Daphne J Holt, Kathryn E Lewandowski, Dost Öngür, Alan Breier, Martha E Shenton and 4 more

Open access · greenAbstract read
In one paragraph

Article in Molecular psychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 2 countries.

Brandee FeolaDepartment of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN, USA.
Adam BeermannDepartment of Psychiatry, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Karlos Manzanarez FelixDepartment of Psychiatry, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Michael ColemanDepartment of Psychiatry, Brigham & Women's Hospital and Harvard Medical School, Boston, MA, USA.
Sylvain BouixDepartment of Software Engineering and Information Technology, École de technologie supérieure, Montréal, QC, Canada.ORCID 0000-0003-1326-6054
Daphne J HoltDepartment of Psychiatry, Massachusetts General Hospital and Harvard Medical School Boston, Boston, MA, USA.
Kathryn E LewandowskiMcLean Hospital and Harvard Medical School, Boston, MA, USA.ORCID 0000-0003-1477-6187
Dost ÖngürMcLean Hospital and Harvard Medical School, Boston, MA, USA.
Alan BreierDepartment of Psychiatry, Indiana University School of Medicine, Indianapolis, IN, USA.
Martha E ShentonDepartment of Psychiatry, Brigham & Women's Hospital and Harvard Medical School, Boston, MA, USA.
Stephan HeckersDepartment of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID 0000-0003-3601-9910
Roscoe O BradyDepartment of Psychiatry, Beth Israel Deaconess Medical Center, Boston, MA, USA.ORCID 0000-0002-2692-6755
Jennifer Urbano BlackfordMunroe-Meyer Institute for Genetics and Rehabilitation, University of Nebraska Medical Center, Omaha, NE, USA.ORCID 0000-0002-0261-4845
Heather Burrell WardDepartment of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN, USA. heather.b.ward@vumc.org.ORCID 0000-0003-2901-8004
Beth Israel Deaconess Medical Center · USHarvard University · USVanderbilt University Medical Center · USBrigham and Women's Hospital · USÉcole de Technologie Supérieure · CAIndiana University School of MedicineNebraska Medical Center · US

Funding

Overall: Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center at VanderbiltP50HD103537 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Lea K Davis · 2020 to 2026
$10.3M
Institutional Career Development CoreKL2TR002245 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Julie A. Bastarache · 2017 to 2026
$9.3M
Academic-Community EPINET (AC-EPINET): Mitigating Barriers to CareR01MH120588 · NIMH · INDIANA UNIVERSITY INDIANAPOLIS · PI BREIER, ALAN · 2020 to 2023
$5.8M
Human Connectome Project for Early PsychosisU01MH109977 · NIMH · BRIGHAM AND WOMEN'S HOSPITAL · PI BREIER, ALAN, SHENTON, MARTHA E. · 2016 to 2020
$5.5M
Network Mediation of Experiential and Expressive Deficits in Psychotic DisordersR01MH116170 · NIMH · BETH ISRAEL DEACONESS MEDICAL CENTER · PI Roscoe O. Brady, KATHRYN Eve LEWANDOWSKI · 2019 to 2026
$5.4M
Negative Valence Systems in SchizophreniaR01MH127018 · NIMH · VANDERBILT UNIVERSITY MEDICAL CENTER · PI FEOLA, BRANDEE, WOODWARD, NEIL D. · 2021 to 2025
$3.3M
Empirical validation of a cerebellar-cortical hallucination circuitR01MH126000 · NIMH · MCLEAN HOSPITAL · PI Roscoe O. Brady, Mark A Halko · 2022 to 2026
$3.3M
Neuroprogression across the Psychosis Spectrum in the Early Course of IllnessR01MH117012 · NIMH · MCLEAN HOSPITAL · PI LEWANDOWSKI, KATHRYN EVE · 2019 to 2023
$2.4M
Network-Targeted Neuromodulation for Nicotine Dependence in SchizophreniaK23DA059690 · NIDA · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Heather Burrell Ward · 2024 to 2026
$557k
NCATS NIH HHS KL2 TR002245NICHD NIH HHS P50 HD103537NIDA NIH HHS K23 DA059690NIMH NIH HHS R01 MH116170NIMH NIH HHS R01 MH117012NIMH NIH HHS R01 MH120588NIMH NIH HHS R01 MH126000NIMH NIH HHS R01 MH127018NIMH NIH HHS U01 MH109977U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (NCATS) KL2TR002245U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) 1R01MH120588-01A1U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) R01MH127018
6 · The paper itself

Abstract

Decades of psychosis research highlight the prevalence and the clinical significance of negative emotions, such as fear and anxiety. Translational evidence demonstrates the pivotal role of the amygdala in fear and anxiety. However, most of these approaches have used hypothesis-driven analyses with predefined regions of interest. A data-driven analysis may provide a complimentary, unbiased approach to identifying brain correlates of fear and anxiety. The aim of the current study was to identify the brain basis of fear and anxiety in early psychosis and controls using a data-driven approach. We analyzed data from the Human Connectome Project for Early Psychosis, a multi-site study of 125 people with psychosis and 58 controls with resting-state fMRI and clinical characterization. Multivariate pattern analysis of whole-connectome data was used to identify shared and psychosis-specific brain correlates of fear and anxiety using the NIH Toolbox Fear-Affect and Fear-Somatic Arousal scales. We then examined clinical correlations of Fear-Affect scores and connectivity patterns. Individuals with psychosis had higher levels of Fear-Affect scores than controls (p < 0.05). The data-driven analysis identified a cluster encompassing the amygdala and hippocampus where connectivity was correlated with Fear-Affect score (p < 0.005) in the entire sample. The strongest correlate of Fear-Affect was between this cluster and the anterior insula and stronger connectivity was associated with higher Fear-Affect scores (r = 0.31, p = 0.0003). The multivariate pattern analysis also identified a psychosis-specific correlate of Fear-Affect score between the amygdala/hippocampus cluster and a cluster in the ventromedial prefrontal cortex (VMPFC). Higher Fear-Affect scores were correlated with stronger amygdala/hippocampal-VMPFC connectivity in the early psychosis group (r = 0.33, p = 0.002), but not in controls (r = -0.15, p = 0.28). The current study provides evidence for the transdiagnostic role of the amygdala, hippocampus, and anterior insula in the neural basis of fear and anxiety and suggests a psychosis-specific relationship between fear and anxiety symptoms and amygdala/hippocampal-VMPFC connectivity. Our novel data-driven approach identifies novel, psychosis-specific treatment targets for fear and anxiety symptoms and provides complimentary evidence to decades of hypothesis-driven approaches examining the brain basis of threat processing.

Indexed as

AmygdalaAnxietyBrainConnectomeFearMagnetic Resonance ImagingPsychotic DisordersAdolescentAdultFemaleHippocampusHumansMaleYoung Adult

Identifiers

PMID38503924
PMCPMC11411017
OpenAlexW4392954980

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.